Healthcare -
Biotechnology - NASDAQ - US
$ 19.03
4.62 %
$ 14 B
Market Cap
-82.74
P/E
SMMT - CAPITAL EXPENDITURES
Capital Expenditures SMMT - Summit Therapeutics Inc.
-128 K
LAST VALUE
35.32%
2 YEAR CAGR
4.83%
5 YEAR CAGR
-5.14%
10 YEAR CAGR